Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Glioma 3Glioblastoma 2Recurrence 1Oligodendroglioma 1Gliosarcoma 1Glioma, Subependymal 1Ependymoma 1Brain Neoplasms 1Astrocytoma 1

Interventions

poly ICLC 2Radiotherapy 2Biopsy 2lorlatinib 1fluorodopa F 18 1fimepinostat 1Temozolomide 1Surgical Procedures, Operative 1Standard of Care 1Radiation 1Protein Subunit Vaccines 1Practice Guidelines as Topic 1Perfusion Magnetic Resonance Imaging 1Magnetic Resonance Spectroscopy 1Ketoconazole 1Gadolinium DTPA 1Fingolimod Hydrochloride 1Dynamic Contrast Enhanced Magnetic Resonance Imaging 1Donepezil 1Diffusion Magnetic Resonance Imaging 1CUDC-907 12-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Astrocytoma × fluorodopa F 18 × Clear all
NCT01165632 2025-09-02

Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma

Mayo Clinic

Phase EARLY_PHASE1 Completed
24 enrolled
CNSSarcoma

Astrocytoma, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Glioma, Subependymal, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡